{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:25:54Z","timestamp":1790371554809,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the PhD Research Fund of North Sichuan Medical College","award":["CBY24-QDA48"],"award-info":[{"award-number":["CBY24-QDA48"]}]},{"name":"North Sichuan Medical College Innovation Team","award":["CBYTD-2025A04"],"award-info":[{"award-number":["CBYTD-2025A04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07053-4","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:42:21Z","timestamp":1774845741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional crosstalk between neuropeptide FF system and N-type voltage-gated calcium channels in ziconotide-mediated antinociception in mice"],"prefix":"10.1007","author":[{"given":"Guofei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"7053_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1124\/mol.115.101154","volume":"89","author":"G Berecki","year":"2016","unstructured":"Berecki G, Motin L, Adams DJ (2016) Voltage-gated R-type calcium channel inhibition via human \u00b5-, \u03b4-, and \u03ba-opioid receptors is voltage-independently mediated by G\u03b2\u03b3 protein subunits. Mol Pharmacol 89:187\u2013196. https:\/\/doi.org\/10.1124\/mol.115.101154","journal-title":"Mol Pharmacol"},{"issue":"49","key":"7053_CR2","doi-asserted-by":"publisher","first-page":"33754","DOI":"10.1074\/jbc.M114.612614","volume":"289","author":"L Bray","year":"2014","unstructured":"Bray L, Froment C, Pardo P, Candotto C, Burlet-Schiltz O, Zajac JM, Mollereau C, Moul\u00e9dous L (2014) Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor. J Biol Chem 289(49):33754\u201333766. https:\/\/doi.org\/10.1074\/jbc.M114.612614","journal-title":"J Biol Chem"},{"issue":"1","key":"7053_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1074\/jbc.M114.612614","volume":"15","author":"ES Caminski","year":"2022","unstructured":"Caminski ES, Antunes FTT, Souza IA, Dallegrave E, Zamponi GW (2022) Regulation of N-type calcium channels by nociceptin receptors and its possible role in neurological disorders. Mol Brain 15(1):95. https:\/\/doi.org\/10.1074\/jbc.M114.612614","journal-title":"Mol Brain"},{"issue":"20","key":"7053_CR4","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1111\/bph.14461","volume":"175","author":"C Chen","year":"2018","unstructured":"Chen C, Xu B, Shi XR, Zhang MN, Zhang QQ, Zhang T, Zhao WD, Zhang R, Wang ZL, Li N, Fang Q (2018) GpTx-1 and [Ala5, Phe6, Leu26, Arg28]GpTx-1, two peptide NaV 1.7 inhibitors: analgesic and tolerance properties at the spinal level. Br J Pharmacol 175(20):3911\u20133927. https:\/\/doi.org\/10.1111\/bph.14461","journal-title":"Br J Pharmacol"},{"key":"7053_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2024.12.010","volume":"565","author":"D Chen","year":"2025","unstructured":"Chen D, Zhang M, He Y, Wu S, Kuang J, Zhang Z, Xu B, Fang Q (2025) The dual modulating effects of neuropeptide FF on morphine-induced analgesia at the spinal level. Neuroscience 565:247\u2013256. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.010","journal-title":"Neuroscience"},{"key":"7053_CR6","doi-asserted-by":"publisher","unstructured":"Cunningham KL, Littleton JT (2023) Mechanisms controlling the trafficking, localization, and abundance of presynaptic Ca(2+) channels. Front Mol Neurosci. 2022.1116729. https:\/\/doi.org\/10.3389\/fnmol.2022.1116729","DOI":"10.3389\/fnmol.2022.1116729"},{"key":"7053_CR7","doi-asserted-by":"publisher","unstructured":"Drew DJ, Gordon DB, Morgan B, Manworren RCB (2018) \u2018As-Needed\u2019\u2019 range orders for opioid analgesics in the management of pain: a consensus statement of the american society for pain management nursing and the american pain society. Pain Manag Nurs. https:\/\/doi.org\/10.1016\/j.pmn.2018.03.003","DOI":"10.1016\/j.pmn.2018.03.003"},{"key":"7053_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/092986611794654012","volume":"18","author":"Q Fang","year":"2011","unstructured":"Fang Q, Jiang TN, Li N, Han ZL, Wang R (2011) Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice. Protein Pept Lett 18:403\u2013409. https:\/\/doi.org\/10.2174\/092986611794654012","journal-title":"Protein Pept Lett"},{"issue":"5","key":"7053_CR9","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1213\/ANE.0000000000000921","volume":"121","author":"ZL Han","year":"2015","unstructured":"Han ZL, Wang ZL, Li XH, Li N, Pan JX, Zheng T, Fang Q, Wang R (2015) Neuropeptide VF enhances cannabinoid agonist WIN55,212-2-induced antinociception in mice. Anesth Analg 121(5):1360\u20131368. https:\/\/doi.org\/10.1213\/ANE.0000000000000921","journal-title":"Anesth Analg"},{"key":"7053_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2016.10.001","volume":"32","author":"J Huang","year":"2017","unstructured":"Huang J, Zamponi GW (2017) Regulation of voltage gated calcium channels by GPCRs and post-translational modification. Curr Opin Pharmacol 32:1\u20138. https:\/\/doi.org\/10.1016\/j.coph.2016.10.001","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"7053_CR11","first-page":"549","volume":"24","author":"J Karri","year":"2021","unstructured":"Karri J, Singh M, Modi DJ, Orhurhu V, Seale C, Saulino M, Marathe A, Vydra D, Hagedorn JM, Bruel B, Abd-Elsayed A (2021) Combination intrathecal drug therapy strategies for pain management. Pain Physician 24(8):549\u2013569. https:\/\/pubmed.ncbi.nlm.nih.gov\/34793643\/","journal-title":"Pain Physician"},{"issue":"5","key":"7053_CR12","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.peptides.2005.07.025","volume":"27","author":"F Kersant\u00e9","year":"2006","unstructured":"Kersant\u00e9 F, Mollereau C, Zajac JM, Roumy M (2006) Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. Peptides 27(5):980\u2013989. https:\/\/doi.org\/10.1016\/j.peptides.2005.07.025","journal-title":"Peptides"},{"issue":"6","key":"7053_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s12264-019-00378-5","volume":"35","author":"Q Li","year":"2019","unstructured":"Li Q, Lu J, Zhou XX, Chen XM, Su DS, Gu XY, Yu WF (2019) High-voltage-activated calcium channel in the afferent pain pathway: an important target of pain therapies. Neurosci Bull 35(6):1073\u20131084. https:\/\/doi.org\/10.1007\/s12264-019-00378-5","journal-title":"Neurosci Bull"},{"issue":"9","key":"7053_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4155\/fmc.12.67","volume":"4","author":"JV Mankus","year":"2012","unstructured":"Mankus JV, McCurdy CR (2012) Nonpeptide ligands of neuropeptide FF: current status and structural insights. Future Med Chem 4(9):1085\u20131092. https:\/\/doi.org\/10.4155\/fmc.12.67","journal-title":"Future Med Chem"},{"issue":"5","key":"7053_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/ner.12392","volume":"19","author":"GC McDowell","year":"2016","unstructured":"McDowell GC, Pope JE (2016) Intrathecal ziconotide: dosing and administration strategies in patients with refractory chronic pain. Neuromodulation 19(5):522\u2013532. https:\/\/doi.org\/10.1111\/ner.12392","journal-title":"Neuromodulation"},{"issue":"3","key":"7053_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1124\/mol.104.004614","volume":"67","author":"C Mollereau","year":"2005","unstructured":"Mollereau C, Mazarguil H, Zajac JM, Roumy M (2005) Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol Pharmacol 67(3):965\u2013975. https:\/\/doi.org\/10.1124\/mol.104.004614","journal-title":"Mol Pharmacol"},{"issue":"7","key":"7053_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1113\/jphysiol.2012.228429","volume":"590","author":"SS Murali","year":"2012","unstructured":"Murali SS, Napier IA, Rycroft BK, Christie MJ (2012) Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels. J Physiol 590(7):1655\u20131667. https:\/\/doi.org\/10.1113\/jphysiol.2012.228429","journal-title":"J Physiol"},{"issue":"21","key":"7053_CR18","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1021\/acs.jmedchem.0c00643","volume":"63","author":"T Nguyen","year":"2020","unstructured":"Nguyen T, Marusich J, Li JX, Zhang Y (2020) Neuropeptide FF and its receptors: therapeutic applications and ligand development. J Med Chem 63(21):12387\u201312402. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00643","journal-title":"J Med Chem"},{"issue":"1\u20133","key":"7053_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(96)00210-5","volume":"306","author":"M Roumy","year":"1996","unstructured":"Roumy M, Zajac JM (1996) Effects of neuropeptide FF on intracellular Ca2+ in mouse spinal ganglion neurons. Eur J Pharmacol 306(1\u20133):291\u2013295. https:\/\/doi.org\/10.1016\/0014-2999(96)00210-5","journal-title":"Eur J Pharmacol"},{"key":"7053_CR20","doi-asserted-by":"publisher","first-page":"20214549049","DOI":"10.1155\/2021\/4549049","volume":"11","author":"SF Sun","year":"2021","unstructured":"Sun SF, Sun SL, Meng Y, Shi B, Chen YZ (2021) Elevated serum neuropeptide FF levels are associated with cognitive decline in patients with spinal cord injury. Dis Markers 11:20214549049. https:\/\/doi.org\/10.1155\/2021\/4549049","journal-title":"Dis Markers"},{"issue":"10","key":"7053_CR21","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/biom10101376","volume":"10","author":"EG Tarlowska","year":"2020","unstructured":"Tarlowska EG, Kotlinska JH (2020) Crosstalk between opioid and anti-opioid systems: an overview and its possible therapeutic significance. Biomolecules 10(10):1376. https:\/\/doi.org\/10.3390\/biom10101376","journal-title":"Biomolecules"},{"issue":"7","key":"7053_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/AJP.0b013e3181e017df","volume":"26","author":"MS Wallace","year":"2010","unstructured":"Wallace MS, Rauck RL, Deer T (2010) Ziconotide combination intrathecal therapy: rationale and evidence. Clin J Pain 26(7):635\u2013644. https:\/\/doi.org\/10.1097\/AJP.0b013e3181e017df","journal-title":"Clin J Pain"},{"key":"7053_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0304-3959(99)00214-6","volume":"84","author":"YX Wang","year":"2000","unstructured":"Wang YX, Gao D, Pettus M, Phillips C, Bowersox SS (2000) Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Pain 84:271\u2013281. https:\/\/doi.org\/10.1016\/s0304-3959(99)00214-6","journal-title":"Pain"},{"issue":"5","key":"7053_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10571-020-00894-3","volume":"41","author":"N Weiss","year":"2021","unstructured":"Weiss N, Zamponi GW (2021) Opioid Receptor regulation of neuronal voltage-gated calcium channels. Cell Mol Neurobiol 41(5):83\u2013847. https:\/\/doi.org\/10.1007\/s10571-020-00894-3","journal-title":"Cell Mol Neurobiol"},{"key":"7053_CR25","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1152\/jn.1995.73.5.1793","volume":"73","author":"MD Womack","year":"1995","unstructured":"Womack MD, McCleskey EW (1995) Interaction of opioids and membrane potential to modulate Ca2+ channels in rat dorsal root ganglion neurons. J Neurophysiol 73:1793\u20131798. https:\/\/doi.org\/10.1152\/jn.1995.73.5.1793","journal-title":"J Neurophysiol"},{"key":"7053_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2007.06.004","volume":"42","author":"YT Yang","year":"2008","unstructured":"Yang YT, Tao T, Iadarola MJ (2008) Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides 42:1\u201318. https:\/\/doi.org\/10.1016\/j.npep.2007.06.004","journal-title":"Neuropeptides"},{"issue":"7","key":"7053_CR28","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.bbamem.2012.10.004","volume":"1828","author":"GW Zamponi","year":"2013","unstructured":"Zamponi GW, Currieb KPM (2013) Regulation of CaV2 calcium channels by G protein coupled receptors. Biochim et Biophys Acta 1828(7):1629\u20131643. https:\/\/doi.org\/10.1016\/j.bbamem.2012.10.004","journal-title":"Biochim et Biophys Acta"},{"issue":"1","key":"7053_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","volume":"60","author":"GW Zamponi","year":"2009","unstructured":"Zamponi GW, Lewis RJ, Todorovic SM, Arneric SP, Snutch TP (2009) Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Rev 60(1):84\u201389. https:\/\/doi.org\/10.1016\/j.brainresrev.2008.12.021","journal-title":"Brain Res Rev"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07053-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:42:34Z","timestamp":1774845754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07053-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":28,"alternative-id":["7053"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07053-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}